223 related articles for article (PubMed ID: 30573850)
21. Hodgkinoid histiocytosis: an atypical nodal CD30 and S100-positive histiocytosis with eosinophilia.
Tsuyama N; Noguchi M; Asaka R; Sakata S; Baba S; Izumi H; Takeuchi K
Histopathology; 2022 Sep; 81(3):371-379. PubMed ID: 35789115
[TBL] [Abstract][Full Text] [Related]
22. Novel ANKRD26 and PDGFRB gene mutations in pediatric case of non-Langerhans cell histiocytosis: Case report and literature review.
Fayiga FF; Reyes-Hadsall SC; Moreno BA; Oh KS; Brathwaite C; Duarte AM
J Cutan Pathol; 2023 May; 50(5):425-429. PubMed ID: 36753059
[TBL] [Abstract][Full Text] [Related]
23. Pediatric liver failure with massive sinusoidal infiltration of histiocytes.
Irie R; Shioda Y; Osumi T; Sakamoto KI; Kasahara M; Matsumoto K; Nakazawa A
J Clin Exp Hematop; 2022 Mar; 62(1):25-34. PubMed ID: 34840207
[TBL] [Abstract][Full Text] [Related]
24. Infantile inflammatory myofibroblastic tumors: clinicopathological and molecular characterization of 12 cases.
Lopez-Nunez O; John I; Panasiti RN; Ranganathan S; Santoro L; Grélaud D; Wu T; Buccoliero AM; Casanova M; Alaggio R; Surrey LF
Mod Pathol; 2020 Apr; 33(4):576-590. PubMed ID: 31690781
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature.
Castro EC; Blazquez C; Boyd J; Correa H; de Chadarevian JP; Felgar RE; Graf N; Levy N; Lowe EJ; Manning JT; Proytcheva MA; Senger C; Shayan K; Sterba J; Werner A; Surti U; Jaffe R
Pediatr Dev Pathol; 2010; 13(3):225-37. PubMed ID: 19642834
[TBL] [Abstract][Full Text] [Related]
26. Congenital histiocytosis. A heterogeneous group of diseases, one presenting as so-called congenital self-healing histiocytosis.
Kodet R; Elleder M; De Wolf-Peeters C; Mottl H
Pathol Res Pract; 1991 May; 187(4):458-66. PubMed ID: 1908575
[TBL] [Abstract][Full Text] [Related]
27. Genomic heterogeneity of ALK fusion breakpoints in non-small-cell lung cancer.
Rosenbaum JN; Bloom R; Forys JT; Hiken J; Armstrong JR; Branson J; McNulty S; Velu PD; Pepin K; Abel H; Cottrell CE; Pfeifer JD; Kulkarni S; Govindan R; Konnick EQ; Lockwood CM; Duncavage EJ
Mod Pathol; 2018 May; 31(5):791-808. PubMed ID: 29327716
[TBL] [Abstract][Full Text] [Related]
28. An Atypical Myelomonocytic Cell Infiltrate: Use of Next-Generation Sequencing to Diagnose Indeterminate Cell Histiocytosis.
Belina ME; Kwock JT; Al-Rohil R; Fresco A
Am J Dermatopathol; 2022 Jul; 44(7):529-531. PubMed ID: 35234186
[TBL] [Abstract][Full Text] [Related]
29. Deep RNA Sequencing Revealed Fusion Junctional Heterogeneity May Predict Crizotinib Treatment Efficacy in ALK-Rearranged NSCLC.
Song Z; Lian S; Mak S; Chow MZ; Xu C; Wang W; Keung HY; Lu C; Kebede FT; Gao Y; Cheuk W; Cho WCS; Yang M; Zheng Z
J Thorac Oncol; 2022 Feb; 17(2):264-276. PubMed ID: 34626839
[TBL] [Abstract][Full Text] [Related]
30. Case Report: ALK-Positive Histiocytosis With
Guo Y; Qu HB; Ning G; Jia FL; Liu H; Ma XM; Liao Y
Front Oncol; 2022; 12():858939. PubMed ID: 35359354
[TBL] [Abstract][Full Text] [Related]
31. The clinical responses of TNIP2-ALK fusion variants to crizotinib in ALK-rearranged lung adenocarcinoma.
Feng T; Chen Z; Gu J; Wang Y; Zhang J; Min L
Lung Cancer; 2019 Nov; 137():19-22. PubMed ID: 31521978
[TBL] [Abstract][Full Text] [Related]
32. Case Report: Rare Systemic and Aggressive ALK-Positive Histiocytosis With Recurrent Pancreatitis Treating by
Li Y; Shi C; Wu Y; He M; Xia X; Liu J; Jiang Y
Front Med (Lausanne); 2022; 9():840407. PubMed ID: 35665359
[TBL] [Abstract][Full Text] [Related]
33. ALK fusion gene positive lung cancer and 3 cases treated with an inhibitor for ALK kinase activity.
Kimura H; Nakajima T; Takeuchi K; Soda M; Mano H; Iizasa T; Matsui Y; Yoshino M; Shingyoji M; Itakura M; Itami M; Ikebe D; Yokoi S; Kageyama H; Ohira M; Nakagawara A
Lung Cancer; 2012 Jan; 75(1):66-72. PubMed ID: 21757253
[TBL] [Abstract][Full Text] [Related]
34. Central nervous system involvement of systemic ALK-positive histiocytosis with
Aoki Y; Maeda M; Kishi S; Kogue R; Tanaka F; Umino M; Takeoka M; Hanaki R; Hirayama J; Yuasa H; Imai H; Hirayama M; Sakuma H
Radiol Case Rep; 2022 Oct; 17(10):3867-3870. PubMed ID: 35982724
[TBL] [Abstract][Full Text] [Related]
35. NTRK expression is common in xanthogranuloma and is associated with the solitary variant.
Umphress B; Kuhar M; Kowal R; Alomari AK; Baldridge LA; Ross AJ; Warren SJ
J Cutan Pathol; 2023 Nov; 50(11):991-1000. PubMed ID: 37580954
[TBL] [Abstract][Full Text] [Related]
36. A case of ALK-positive histiocytosis with multiple lesions in the unilateral breast: A case report.
Kurita A; Yoshida M; Murata T; Yoshida A; Uchiyama N; Takayama S
Int J Surg Case Rep; 2022 Aug; 97():107435. PubMed ID: 35908452
[TBL] [Abstract][Full Text] [Related]
37. A rare KIF5B-ALK fusion variant in a lung adenocarcinoma patient who responded to crizotinib and acquired the ALK L1196M mutation after resistance: a case report.
Zeng H; Liu Y; Wang W; Tang Y; Tian P; Li W
Ann Palliat Med; 2021 Jul; 10(7):8352-8357. PubMed ID: 33832282
[TBL] [Abstract][Full Text] [Related]
38. Integrated molecular profiling of juvenile myelomonocytic leukemia.
Murakami N; Okuno Y; Yoshida K; Shiraishi Y; Nagae G; Suzuki K; Narita A; Sakaguchi H; Kawashima N; Wang X; Xu Y; Chiba K; Tanaka H; Hama A; Sanada M; Ito M; Hirayama M; Watanabe A; Ueno T; Kojima S; Aburatani H; Mano H; Miyano S; Ogawa S; Takahashi Y; Muramatsu H
Blood; 2018 Apr; 131(14):1576-1586. PubMed ID: 29437595
[TBL] [Abstract][Full Text] [Related]
39. GCC2-ALK as a targetable fusion in lung adenocarcinoma and its enduring clinical responses to ALK inhibitors.
Jiang J; Wu X; Tong X; Wei W; Chen A; Wang X; Shao YW; Huang J
Lung Cancer; 2018 Jan; 115():5-11. PubMed ID: 29290262
[TBL] [Abstract][Full Text] [Related]
40. Disseminated ALK-positive histiocytosis with
Qiu L; Weitzman SP; Nastoupil LJ; Williams MD; Medeiros LJ; Vega F
Leuk Lymphoma; 2021 May; 62(5):1234-1238. PubMed ID: 33353436
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
